
Deklot 5mg Tablet
Marketer
Grownbury Pharmaceuticals Pvt Ltd
Salt Composition
Prasugrel (5mg)
Overview Deklot 5mg Tablet
CardioGuard 5mg tablets are antiplatelet agents, also known as blood thinners. They prevent the formation of dangerous blood clots, ensuring smooth blood flow. This reduces the risk of subsequent heart attacks or strokes in individuals with heart conditions. CardioGuard 5mg is indicated for patients recovering from a recent heart attack, experiencing severe chest pain (unstable angina), or post-stent placement. It safeguards against major cardiac events, such as recurrent heart attacks, strokes, or stent thrombosis. This medication may be co-prescribed with aspirin, another antiplatelet drug. It can be taken with or without food, consistently at the same time daily. Continued use, even when feeling well, is crucial; discontinuation increases the risk of cardiovascular events. The most frequent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While usually mild and self-limiting, persistent or concerning bleeding requires immediate medical attention. This medication is contraindicated in individuals with active bleeding (e.g., ulcers, intracranial hemorrhage), or severe hepatic impairment. Prior to initiating treatment, disclose any history of bleeding disorders, recent major trauma, or upcoming surgery to your physician. Temporary cessation may be necessary before scheduled procedures.
Primary Ingredients of Deklot 5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Deklot 5mg Tablet
Avoiding heart attacks and strokes
Major Benefits of Deklot 5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Deklot 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Deklot 5mg Tablet:
- Bleeding
How to use Deklot 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Deklot tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Deklot 5mg Tablet works:
CardioGuard 5mg tablets are prescribed to inhibit platelet aggregation. Their mechanism of action prevents platelet clumping, reducing the risk of dangerous thrombus formation. Consequently, the likelihood of recurrent cardiac events, such as stroke or myocardial infarction, is diminished.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Deklot 5mg tablets does not produce adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data on Deklot 5mg Tablet is absent. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Deklot 5mg Tablet use while breastfeeding is absent. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Deklot 5mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Deklot 5mg Tablets in individuals with kidney disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Deklot 5mg tablets; dosage modification may be necessary. Consult a physician for guidance. Data regarding Deklot 5mg tablet use in such patients is limited. Dosage alteration is not advised for those with mild to moderate liver dysfunction.
What if you forget to take Deklot 5mg Tablet :
Should you forget to take your Deklot 5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Deklot 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | ADP receptor antagonists (P2Y12 inhibitors) |
